E-LIB Suche - Ergebnisse für: Hawkes, E

1

IMMUNE CONTEXTURE ANALYSIS IN POLARIX SUGGESTS RESPONSE TO ..:

Morschhauser, F. ; Hatzi, K. ; Lenz, G....
Hematological Oncology. 41 (2023) S2 - p. 223-225 , 2023

Link: https://doi.org/10.1002/..

2

Interim 3‐Dimensional volumetric response (3DVR) is associa..:

Martynchyk, A. ; O'Shaughnessy, J. ; Lee, S....
Hematological Oncology. 41 (2023) S2 - p. 349-350 , 2023

Link: https://doi.org/10.1002/..

3

Radiotherapy (RT) & Durvalumab in Relapsed/Refractory Diffu..:

Hawkes, E. A. ; Palmer, J. ; Chong, G....
Hematological Oncology. 41 (2023) S2 - p. 599-600 , 2023

Link: https://doi.org/10.1002/..

4

Gene expression and spatial transcriptomic analysis of pair..:

Swain, F. ; Burgess, M. ; Kempe, S....
Hematological Oncology. 41 (2023) S2 - p. 278-279 , 2023

Link: https://doi.org/10.1002/..

5

First‐in‐Human (FIH) Study of the Fully‐Human Kappa‐Lambda ..:

Hawkes, E. A. ; Lewis, K. L. ; Doo, N. Wong...
Hematological Oncology. 41 (2023) S2 - p. 579-580 , 2023

Link: https://doi.org/10.1002/..

6

T cell CD62L expression following nivolumab therapy is asso..:

Koldej, R. M. ; Barraclough, A. ; Lee, S. T....
Hematological Oncology. 41 (2023) S2 - p. 272-272 , 2023

Link: https://doi.org/10.1002/..

7

Final analysis of Australasian Leukaemia & Lymphoma Group N..:

Verner, E. ; Johnston, A. ; Pati, N....
Hematological Oncology. 41 (2023) S2 - p. 426-427 , 2023

Link: https://doi.org/10.1002/..

8

POLATUZUMAB, BENDAMUSTINE & RITUXIMAB EFFICACY IN RELAPSED/..:

Shaw, B. ; Chung, E. ; Wellard, C....
Hematological Oncology. 41 (2023) S2 - p. 718-719 , 2023

Link: https://doi.org/10.1002/..

9

Mature T and NK cell lymphomas classified according to 2016..:

Manni, M. ; Chiattone, C. S. ; Prince, M. H....
Hematological Oncology. 41 (2023) S2 - p. 311-312 , 2023

Link: https://doi.org/10.1002/..

10

AVELUMAB MONOTHERAPY FOLLOWED BY A PET ADAPTED CHEMOTHERAPY..:

Collins, G. P. ; Hawkes, E. A. ; Kirkwood, A. A....
Hematological Oncology. 41 (2023) S2 - p. 162-163 , 2023

Link: https://doi.org/10.1002/..

11

P1187: END OF TREATMENT 18F FDG-PET/CT RESPONSE IS PROGNOST..:

Gleeson, M. ; Arias, C. ; Cunningham, D....
HemaSphere. 6 (2022) - p. 1073-1074 , 2022

Link: https://doi.org/10.1097/..

12

P1162: ZANUBRUTINIB IN OLDER PATIENTS (PTS) WITH RELAPSED/R..:

Opat, S. ; Hu, B. ; Tedeschi, A....
HemaSphere. 6 (2022) - p. 1049-1050 , 2022

Link: https://doi.org/10.1097/..

13

S219: FIRST CLINICAL STUDY OF THE ANTI-SIGNAL REGULATORY PR..:

Strati, P. ; Hawkes, E. ; Ghosh, N....
HemaSphere. 6 (2022) - p. 120-121 , 2022

Link: https://doi.org/10.1097/..

14

P1261: ALLG LABORATORY SCIENCE STUDY LS21: MOLECULAR CORREL..:

Tatarczuch, M. ; Waltham, M. ; Shortt, J....
HemaSphere. 6 (2022) - p. 1146-1147 , 2022

Link: https://doi.org/10.1097/..

15

S222: MATURE T AND NK CELL LYMPHOMAS CLASSIFIED ACCORDING T..:

Federico, M. ; Stepanishyna, Y. ; Skrypets, T....
HemaSphere. 6 (2022) - p. 123-124 , 2022

Link: https://doi.org/10.1097/..